← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Creative Medical Technology CELZ $6.07M	–	–	–	–
52	52 DELISTED CERo Therapeutics CERO	–	–	–	–
53	53 Calidi Biotherapeutics CLDI $2.28M	–	–	–	–
54	54 Cellectis CLLS $111M	–	–	–	–
55	55 Coya Therapeutics COYA $103M	–	–	–	–
56	56 Caribou Biosciences CRBU $48M	–	–	–	–
57	57 DELISTED CARGO Therapeutics CRGX	–	–	–	–
58	58 CRISPR Therapeutics CRSP $4.96B	–	–	–	–
59	CYAD 59 DELISTED Celyad Oncology SA American Depositary Shares CYAD	–	–	–	–
60	DBTX 60 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
61	61 Precision BioSciences DTIL $168M	–	–	–	–
62	62 enGene Therapeutics ENGN $112M	–	–	–	–
63	63 Estrella Immunopharma ESLA $14M	–	–	–	–
64	64 FibroBiologics FBLG $7.15M	–	–	–	–
65	65 4D Molecular Therapeutics FDMT $694M	–	–	–	–
66	FRLN 66 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
67	67 DELISTED Generation Bio GBIO	–	–	–	–
68	68 CytoMed Therapeutics GDTC $10M	–	–	–	–
69	GMDA 69 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
70	70 Genprex GNPX $1.93M	–	–	–	–
71	71 Genenta Science GNTA $32.5M	–	–	–	–
72	GRCL 72 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
73	GRML 73 Greenland Mines Ltd GRML $81.8M	–	–	–	–
74	74 Fractyl Health GUTS $55M	–	–	–	–
75	75 Immix Biopharma IMMX $720M	–	–	–	–